{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/fungal-skin-infection-foot/prescribing-information/topical-antifungals/","result":{"pageContext":{"chapter":{"id":"27a2a883-b20f-5b25-825b-3bc5b02c1f77","slug":"topical-antifungals","fullItemName":"Topical antifungals","depth":2,"htmlHeader":"<!-- begin field 39d44c09-f755-4c9c-a824-d89be4602bd6 --><h2>Topical antifungals</h2><!-- end field 39d44c09-f755-4c9c-a824-d89be4602bd6 -->","summary":"","htmlStringContent":"<!-- begin item e5a4a6e5-4993-45d8-8cc1-03d7684f9189 --><!-- end item e5a4a6e5-4993-45d8-8cc1-03d7684f9189 -->","topic":{"id":"32650c82-f347-5933-adc6-d0da00f3d764","topicId":"35b0fa0c-8988-453f-af54-60cd595d29ad","topicName":"Fungal skin infection - foot","slug":"fungal-skin-infection-foot","lastRevised":"Last revised in April 2018","chapters":[{"id":"66fe4516-176d-5ffc-aebd-99a58afbd57c","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"5231c18b-820c-586e-87f0-5527574f70d1","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"e2b3169b-582d-5dda-b94f-73ccd139eede","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"8e1fd155-8f48-5bf7-a40c-4d2931a41736","slug":"changes","fullItemName":"Changes"},{"id":"8249fd1f-7c27-535b-a721-9e280d761ea5","slug":"update","fullItemName":"Update"}]},{"id":"e4ea5f16-99ef-5247-87e9-141b06d8b21a","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"524d92eb-2792-5543-a6d9-78e4f825cf22","slug":"goals","fullItemName":"Goals"},{"id":"a678e6e3-5a4b-55cb-b7d6-c6ab9580eda2","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"44708a93-b41d-5827-9293-650b191df0b0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5d578224-3b80-58f6-9894-5c90e41c1b44","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a029f7b6-3344-51e6-ab22-bafdf196a4b7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b487a461-1526-54bb-a2df-4e2e0562293d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0e034d35-5e8d-5db3-a518-77103caa73c8","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"73e18fb0-6f03-51ed-bddf-355959375e75","slug":"definition","fullItemName":"Definition"},{"id":"a33dea25-362f-5128-9c14-d178ef837bfe","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"a4167228-e44b-560b-8406-20294a5b8e42","slug":"prevalence","fullItemName":"Prevalence"},{"id":"91f3fb6f-6926-547c-830c-dd963749fb55","slug":"complications","fullItemName":"Complications"},{"id":"8373f46b-763e-53e3-9ea8-90cd767d66e6","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"090da929-a640-586e-a803-a47b38656e1d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"024c307f-3650-539d-b0b4-4f1c4a8db49e","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"e3544fc8-cba9-524d-aed2-f28ae6f802e8","slug":"assessment","fullItemName":"Assessment"},{"id":"3ad14837-2b4c-58ab-b5c5-456d63d403ae","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"db051fa9-f61e-5787-bd5d-b2ff4a77ba85","fullItemName":"Management","slug":"management","subChapters":[{"id":"a11a4a32-6cc1-5c40-8396-099a218e1487","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"d96bb08c-b21d-517b-830e-ead35a26fe8e","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"27a2a883-b20f-5b25-825b-3bc5b02c1f77","slug":"topical-antifungals","fullItemName":"Topical antifungals"},{"id":"476702d7-9e1a-5dfd-b3b0-899ebce5130b","slug":"oral-terbinafine","fullItemName":"Oral terbinafine"},{"id":"e3c1f25f-1a76-53af-aef4-b39eecdf04d7","slug":"oral-itraconazole","fullItemName":"Oral itraconazole"},{"id":"4f73cab3-f311-54bd-beac-8bb860f26e2f","slug":"oral-griseofulvin","fullItemName":"Oral griseofulvin"}]},{"id":"aaec6565-5327-5bd4-bc06-a1442065c1bd","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c64c0494-1e71-5960-a8c9-a05141d2801c","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"265ba112-5e5e-59c8-8569-29d1a263263d","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"e7088451-abf0-5e2f-a546-109de8062cbf","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"96559e5f-dca9-5c90-af8c-c1182e5d3306","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"bd075cd9-9444-5680-bd23-a168ebe2b5a2","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"49b473c6-a745-5480-9602-1224549611f7","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"65b0f432-1967-593c-a9f7-2326776f4e83","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"d96bb08c-b21d-517b-830e-ead35a26fe8e","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"16733aac-44b9-5be5-a19b-fc96d7380f5f","slug":"application","fullItemName":"Application","depth":3,"htmlHeader":"<!-- begin field 76cefb62-64c3-4396-bdb9-a8d200b505db --><h3>Application</h3><!-- end field 76cefb62-64c3-4396-bdb9-a8d200b505db -->","summary":"","htmlStringContent":"<!-- begin item 1f54be99-95f6-48ac-83fb-a8d200b50434 --><!-- begin field 688ec8d2-1049-4dc2-8c99-a8d200b505db --><p><strong>The following application regimens are recommended for the treatment of fungal foot infection:</strong></p><ul><li><strong>Terbinafine 1% cream (children above 12 years of age)</strong><ul><li>Apply thinly to the affected area once or twice a day for up to 7 days.</li></ul></li><li><strong>Clotrimazole 1% cream</strong><ul><li>Apply to the affected area 2–3 times a day and continue for at least 4 weeks. A strip of cream about half a centimetre long is enough to treat an area about the size of the hand.</li></ul></li><li><strong>Miconazole 2% cream</strong><ul><li>Apply to the affected area twice a day for 2–6 weeks depending on the severity of the lesions, and continue for 10 days after all skin lesions are healed.</li></ul></li><li><strong>Econazole 1% cream</strong><ul><li>Apply to the affected area twice a day and continue until all skin lesions are healed.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">ABPI Medicines Compendium, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">ABPI, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">ABPI, 2015b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">ABPI Medicines Compendium, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">BNF for Children, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">BNF 75, 2018</a>] </p><!-- end field 688ec8d2-1049-4dc2-8c99-a8d200b505db --><!-- end item 1f54be99-95f6-48ac-83fb-a8d200b50434 -->","subChapters":[]},{"id":"db9939e9-71e3-543e-9b88-de906c54a768","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field e16ddf3a-39bf-48e8-974d-a8d200b3b6d4 --><h3>Contraindications and cautions</h3><!-- end field e16ddf3a-39bf-48e8-974d-a8d200b3b6d4 -->","summary":"","htmlStringContent":"<!-- begin item 5fa72205-f456-4d68-a26d-a8d200b3b363 --><!-- begin field 036744d7-9809-4f4c-abc0-a8d200b3b6d4 --><ul><li><strong>Terbinafine 1% cream is licensed for the treatment of fungal foot infection above the age of 12 years.</strong></li><li><strong>Clotrimazole 1% cream, miconazole 2% cream, and econazole 1% cream are licensed for the treatment of fungal foot infection in children and adults.</strong><ul><li>Advise the person to avoid contact with the eyes and mucous membranes during use.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">ABPI Medicines Compendium, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">BNF for Children, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">BNF 75, 2018</a>] </p><!-- end field 036744d7-9809-4f4c-abc0-a8d200b3b6d4 --><!-- end item 5fa72205-f456-4d68-a26d-a8d200b3b363 -->","subChapters":[]},{"id":"e926ea8d-d5df-516c-93f9-a4eac71dd5b0","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 51be0547-85f7-4f6d-9592-a8d200b3e9f8 --><h3>Adverse effects</h3><!-- end field 51be0547-85f7-4f6d-9592-a8d200b3e9f8 -->","summary":"","htmlStringContent":"<!-- begin item 1a4e14fd-e7b0-4874-9fbd-a8d200b3e79c --><!-- begin field 765bf8fc-66aa-4e84-8f34-a8d200b3e9f8 --><ul><li><strong>Possible adverse effects with topical antifungals are uncommon</strong> and may include erythema, hypersensitivity reactions, itching, mild burning sensation, occasional local irritation.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">BNF for Children, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">BNF 75, 2018</a>] </p><!-- end field 765bf8fc-66aa-4e84-8f34-a8d200b3e9f8 --><!-- end item 1a4e14fd-e7b0-4874-9fbd-a8d200b3e79c -->","subChapters":[]},{"id":"8bbda2d9-041c-5396-93ea-dc3545450b7f","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field d54d8aa8-8850-4b48-8f1e-a8d200b40cd7 --><h3>Drug interactions</h3><!-- end field d54d8aa8-8850-4b48-8f1e-a8d200b40cd7 -->","summary":"","htmlStringContent":"<!-- begin item 4c33f7a7-fa23-4366-b66b-a8d200b40b31 --><!-- begin field 40ea2b0a-f9d8-4f89-9f61-a8d200b40cd7 --><ul><li>Topical terbinafine cream — there are no known significant drug interactions.</li><li>Topical clotrimazole cream — there are no known significant drug interactions.</li><li>Topical miconazole and econazole cream — oral miconazole and econazole are known to interact with oral anticoagulants, but due to the limited systemic availability of topical preparations, clinically relevant drug interactions are rare. The manufacturer advises, however, that caution should be exercised and the anticoagulant effect should be monitored during concurrent use with an oral anticoagulant.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">ABPI Medicines Compendium, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">ABPI, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">ABPI, 2015b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-skin-infection-foot/references/\">ABPI Medicines Compendium, 2016</a>] </p><!-- end field 40ea2b0a-f9d8-4f89-9f61-a8d200b40cd7 --><!-- end item 4c33f7a7-fa23-4366-b66b-a8d200b40b31 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}